| Labatec Pharma SA - Ovaleap 450 IU/0.75 ml, solution injectable |
| 66255 | | 02 | | Ovaleap 450 IU/0.75 ml | | solution injectable | | G03GA05 | | Follitropin alfa | | 28.08.2018 | | |
|
| Composition |
| follitropinum alfa 450 U.I., natrii dihydrogenophosphas dihydricus, mannitolum, polysorbatum 20, antiox.: methioninum 375 µg, conserv.: alcohol benzylicus 7.5 mg, benzalkonii chloridum 15 µg, aqua ad iniectabile q.s. ad solutionem pro 0.75 ml. |
| Packungsbestandteile |
| Solution injectable | | | | | | | | Principe actif | Concentr. |
|---|
| Follitropine Alfa | 450U.I. / 0.75ml |
| | BAG: Principe actif | Concentr. |
|---|
| Follitropine Alfa | 450 UI |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Alcohol Benzylicus | 7.5mg / 0.75ml | conserv. | | Benzalkonium Chlorure | 15µg / 0.75ml | | | Mannitol | | | | Methionine | 375µg / 0.75ml | antiox. | | Sodium Dihydrogenophosphate Dihydrate | | | | Polysorbatum 20 | | |
| |
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 002 | | 138.12 | 166.65 | A | LS | Non |
|
